IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
NCT00524342
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Von Willebrand Disease
Interventions
DRUG:
Oprelvekin, Interleukin 11, IL-11
Sponsor
Margaret Ragni
Collaborators
[object Object]
[object Object]